Key facts
- Bloomlife’s last known valuation is $27.4M (Mar 2025).
- It has raised $35.1M across 2 recorded rounds; the latest was Early Stage VC ($12.9M) in Aug 2024.
- Notable investors include Plug and Play Tech Center, US National Science Foundation, SOSV, MedTech Innovator, Liquid 2 Ventures — 50 tracked in total.
- Bloomlife has filed 2 Form Ds with the SEC since 2017, most recently Sep 2024 ($12.9M sold to 50 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 2 rounds
- ·The complete investor list — 50 names
- ·Watchlist + deal alerts for Bloomlife
Funding rounds
2 roundsAbout Bloomlife
Developer of a remote maternal care platform designed to improve the health of mothers and babies. The company combines connected devices with data analytics to improve access to care, reassure and empower mothers, and help clinicians predict and manage pregnancy complications, includes a prenatal wearable designed to assess fetal health to help identify complications that may lead to brain damage or stillbirth, enabling doctors and women to predict earlier and manage pregnancy complications.
- Sector
- Healthcare
- HQ
- San Francisco, CA, United States
- Founded
- 2014
- Employees
- 35
- Website
- bloom-life.com/
- Ownership
- Privately Held (backing)
Bloomlife doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Bloomlife shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Bloomlife in its N-PORT filings yet. We sweep new filings monthly.